FilingsAtlas Logo - Company Search & Market Tools
FilingsAtlas

SBC Medical Group Holdings Inc (SBC) Financial Statements

Industry: Offices & Clinics of Doctors of Medicine (Services)

In fiscal 2025, SBC Medical reported revenue of $173.6M, down 15.5% from $205.4M the year before. Net income was $51.0M (a 29.4% net margin), or $0.50 per diluted share. Gross margin was 73.3% and operating margin was 38.9%. Operating activities generated $24.7M of cash, leaving $23.3M of free cash flow. At fiscal year end, SBC Medical held $380.4M in total assets against $117.1M in total liabilities, including $163.8M of cash and equivalents.

Open the full interactive SBC Medical financials → Quarterly statements, key ratios, valuation history and price charts.

SBC Medical Key Stats

Share Price$5.32
Market Cap$545.7M
P/E Ratio10.6
Revenue YoY Growth-15.5%
52-Week Range$2.87 – $5.42
Shares Outstanding102.6 million (basic, 2026 Q2)

SBC Medical Income Statement

SBC Medical Group Holdings Inc annual income statement
FY 2023FY 2024FY 2025
Revenue$0$205.4M$173.6M
Gross Profit—$156.1M$127.3M
Operating Income-$1.8M$70.3M$67.5M
Pre-Tax Income$868,576$73.5M$82.1M
Income Tax$528,809$26.8M$31.0M
Net Income$339,767$46.6M$51.0M
Diluted EPS$0.04$0.48$0.50

SBC Medical Quarterly Results

SBC Medical Group Holdings Inc last 4 quarters
2025 Q32025 Q42026 Q12026 Q2
Revenue$43.4M$39.6M$43.1M$49.2M
Net Income$12.8M$14.2M$11.3M$10.7M
Diluted EPS$0.12$0.14$0.11$0.10

SBC Medical Balance Sheet

SBC Medical Group Holdings Inc annual balance sheet (fiscal year end)
FY 2023FY 2024FY 2025
Cash & Equivalents—$125.0M$163.8M
Current Assets$394,543$184.5M$231.2M
Total Assets$21.2M$266.1M$380.4M
Current Liabilities$2.6M$61.2M$61.1M
Total Long-Term Debt—$6.6M$42.8M
Total Liabilities$6.6M$71.1M$117.1M
Shareholders' Equity-$6.0M$195.1M$248.3M

SBC Medical Cash Flow Statement

SBC Medical Group Holdings Inc annual cash flow statement
FY 2023FY 2024FY 2025
Cash From Operations-$2.1M$20.6M$24.7M
Cash From Investing$101.0M-$10.1M-$21.0M
Cash From Financing-$99.1M$23.0M$38.3M
Free Cash Flow—$18.0M$23.3M

Figures from SBC Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full SBC Medical financials page for every line item.

SBC Medical Company Profile

TickerSBC
ExchangeNasdaq
IndustryOffices & Clinics of Doctors of Medicine (Services)
HeadquartersIrvine, California
Incorporated inDelaware
Fiscal Year EndDecember 31
SEC Filer CategoryNon-accelerated filer, smaller reporting company, emerging growth company
SEC CIK0001930313

Frequently Asked Questions

What was SBC Medical's revenue in fiscal 2025?

SBC Medical (SBC) reported revenue of $173.6M for fiscal 2025.

What is SBC Medical's annual revenue history?

SBC Medical's annual revenue by fiscal year: 2023: $0; 2024: $205.4M; 2025: $173.6M.

What was SBC Medical's net income in fiscal 2025?

SBC Medical reported net income of $51.0M for fiscal 2025.

What was SBC Medical's earnings per share (EPS) in fiscal 2025?

SBC Medical's diluted EPS was $0.50 for fiscal 2025 (adjusted for any later stock splits).

How much free cash flow did SBC Medical generate in fiscal 2025?

SBC Medical generated $23.3M of free cash flow in fiscal 2025.

What was SBC Medical's revenue last quarter?

In its most recent reported quarter (2026 Q2), SBC Medical reported revenue of $49.2M.

How much debt does SBC Medical have?

SBC Medical reported $42.8M of long-term debt, including the current portion, at the end of fiscal 2025.

How many shares of SBC Medical are outstanding?

SBC Medical reported a weighted average of 102.6 million basic shares outstanding in 2026 Q2.

What is SBC Medical's market cap?

Based on its latest closing price, SBC Medical (SBC) has a market capitalization of about $545.7M.

When does SBC Medical's fiscal year end?

SBC Medical's fiscal year end, as registered with the SEC, is December 31.

Where is SBC Medical headquartered?

SBC Medical lists its business address in Irvine, California in its SEC filings.